Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (5.558)

81

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) : 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

enthalten in: Human vaccines & immunotherapeutics | 2024

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29

82

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: Human vaccines & immunotherapeutics | 2024

von Goldstein, N. | McLean, C. | Gaddah, A. | +7

83

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

enthalten in: Viruses | 2024

von Hedskog, C. | Spinner, C. | Protzer, U. | +24

84

Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block. Comment on Br J Anaesth 2024; 132 : 45-52

enthalten in: British journal of anaesthesia | 2024

von Miyazaki, Y. | Suzuki, K. | Sunaga, H.

85

A diagnostic phase III/IV seamless design to investigate the diagnostic accuracy and clinical effectiveness using the example of HEDOS and HEDOS II

enthalten in: Statistical methods in medical research | 2024

von Pepić, A. | Stark, M. | Friede, T. | +7

86

Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens : patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

enthalten in: The Lancet. Haematology | 2024

von Delforge, M. | Patel, K. | Eliason, L. | +15

ErratumIn: Lancet Haematol. 2024 Mar 12;:. - PMID 38490233

87

Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4)

enthalten in: Modern rheumatology | 2024

von Tanaka, Y. | Takeuchi, T. | Morita, Y. | +3

88

Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease : A subgroup analysis of a global, randomised, controlled Phase 3 trial

enthalten in: Modern rheumatology | 2024

von Kuwana, M. | Takehara, K. | Tanaka, Y. | +4

89

Reply of the Authors : Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

enthalten in: Fertility and sterility | 2024

von Nelson, S. | Fauser, B. | García-Velasco, J. | +2

90

Long-term efficacy and safety of romiplostim in refractory aplastic anemia : follow-up of a phase 2/3 study

enthalten in: Blood advances | 2024

von Mitani, K. | Lee, J. | Jang, J. | +20